These downstream metabolic factors may be more important than IDO in the regulation of KP and should attract more attention from researchers in the next phase of research, which will help in more precise management of inflammation and psychological conditions in IBD patients. This evidence concerns the gene IDO1 and inflammatory bowel disease.